Abiomed Inc
ABMDDelisted- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000815094
Abiomed Inc was delisted in 2022; its insiders filed their last Form 4 on Dec 27, 2022; 517 institutions reported holding it in 13F filings for Q3 2022, worth $10.6B in total; Maverick Capital was the only superinvestor holding it.
Key figures
- Insider buys
- 0
- Open market, last 90 days
- Insider sells
- 0
- Open market, last 90 days
- 13F holders
- 516
- Q3 2022, +23 vs. previous quarter
- 13F value
- $10.6B
- Reported value at the end of Q3 2022
- Superinvestors holding
- 1
- At the end of Q3 2022
Superinvestors holding ABMD, Q3 2022
1 superinvestor reports holding Abiomed Inc on Form 13F. Percentages are the stock's share of each portfolio.
Latest insider trades
Open-market purchases and sales by Abiomed Inc insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2022 (view filing) | Nov 15-16 | 2 days | Sutter Martin PDirector | SSaleCommon Stock, $0.01 par value | −4.00K | $374.61 | −$1.50M | −3.2%119.4K after | 4 lots |
| Nov 8, 2022 (view filing) | Nov 4 | 4 days | Began Marc AVP & GENERAL COUNSEL | SSaleCommon Stock, $0.01 par value | −2.00K | $373.71 | −$747.4K | −12.7%13.8K after | |
| Nov 3, 2022 (view filing) | Nov 1 | 2 days | Plano Matthew T.VP, GLOBAL OPERATIONS | SSaleCommon Stock $.01 par value | −3.54K | $378.61 | −$1.34M | −25.7%10.3K after | 4 lots |
| Nov 3, 2022 (view filing) | Nov 1 | 2 days | Thomas PaulDirector | SSaleCommon Stock, $.01 par value | −1.00K | $379.38 | −$379.4K | −13.6%6.36K after | |
| Nov 3, 2022 (view filing) | Nov 1 | 2 days | Trapp Todd AVICE PRESIDENT, CFO | SSaleCommon Stock, $0.01 par value | −1.00K | $378.66 | −$378.7K | −5.9%15.9K after | 4 lots |
| Aug 30, 2022 (view filing) | Aug 29 | 1 day | Began Marc AVP & GENERAL COUNSEL | SSaleCommon Stock, $0.01 par value | −500 | $255.95 | −$128.0K | −3.1%15.8K after | |
| Aug 17, 2022 (view filing) | Aug 16-17 | 1 day | Sutter Martin PDirector | SSaleCommon Stock, $0.01 par value | −4.00K | $286.39 | −$1.15M | −3.2%122.8K after | 15 lots |
| Aug 5, 2022 (view filing) | Aug 3 | 2 days | Trapp Todd AVICE PRESIDENT, CFO | SSaleCommon Stock, $0.01 par value | −1.00K | $300.00 | −$300.0K | −5.6%16.9K after | |
| May 19, 2022 (view filing) | May 17-18 | 2 days | Sutter Martin PDirector | SSaleCommon Stock, $0.01 par value | −4.00K | $251.21 | −$1.00M | −3.1%126.4K after | 18 lots |
| Apr 6, 2022 (view filing) | Apr 4 | 2 days | Trapp Todd AVICE PRESIDENT, CFO | SSaleCommon Stock, $0.01 par value | −1.00K | $333.00 | −$333.0K | −7.1%13.1K after |
Top 10 13F holders, Q3 2022
The largest institutional positions in Abiomed Inc at the end of Q3 2022; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 5,269,340 | $1.29B | 0.04% | +287,915+5.8% | Added |
| BlackRock Inc. | 4,560,483 | $1.12B | 0.04% | +30,854+0.7% | Added |
| Baillie Gifford & Co | 3,624,937 | $890.5M | 0.92% | −84,884−2.3% | Reduced |
| State Street Corp | 2,071,180 | $508.8M | 0.03% | −15,590−0.7% | Reduced |
| Primecap Management Co | 1,506,272 | $370.0M | 0.36% | −32,980−2.1% | Reduced |
| Wellington Management Group LLP | 1,453,669 | $357.1M | 0.08% | +263,412+22.1% | Added |
| Generation Investment Management LLP | 1,336,755 | $328.4M | 1.95% | −6,469−0.5% | Reduced |
| Renaissance Technologies LLC | 1,265,800 | $311.0M | 0.44% | −180,723−12.5% | Reduced |
| Brown Capital Management LLC | 1,260,466 | $309.6M | 4.34% | −1,993−0.2% | Reduced |
| Winslow Capital Management, LLC | 1,251,859 | $307.5M | 1.80% | −25,734−2.0% | Reduced |